Article
Lack of association between interleukin-22 gene polymorphisms and cancer risk: a case-control study and a meta-analysis.
International journal of clinical oncology - 1 Apr 2020
Wang Huan, Huang Chao, Liu Yuxiao, Yang Puyu, Liao Yuxiao, Gu Xiuli, Feng Xianhong, Chen Bifeng
Abstract excerpt
BACKGROUND: Interleukin-22 (IL22) has been implicated in inflammation and tumorigenesis. The association between IL22 gene polymorphisms and cancer risk has been widely explored. However, the limited sample sizes of previous studies may produce inadequate statistical power and conflicting results, which calls for further investigations. In this study, we recruited a total of 1490 cancer patients (480 liver cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
